Skip to main content

ADVERTISEMENT

real-world data

Editorial Message
11/01/2022
John C Lantis II
Dr. John C. Lantis II, Clinical Editor, considers the importance of--and difficulty in collecting--real-world data related to patients outcomes.
Dr. John C. Lantis II, Clinical Editor, considers the importance of--and difficulty in collecting--real-world data related to patients outcomes.
Dr. John C. Lantis II, Clinical...
11/01/2022
Wounds
Guest Editorial
04/01/2022
Marcia Nusgart, RPh
Now is a unique time for clinicians to articulate the realities and complexities of wound care.
Now is a unique time for clinicians to articulate the realities and complexities of wound care.
Now is a unique time for...
04/01/2022
Wound Management & Prevention
Abiraterone vs Docetaxel for De Novo Prostate Cancer in Real-World and Trial Settings
Videos
03/18/2021
Daniel Geynisman, MD, discusses results from a study which compared real-world survival among men with de novo metastatic prostate cancer treated with abiraterone acetate or docetaxel and compared these outcomes to those seen in clinical...
Daniel Geynisman, MD, discusses results from a study which compared real-world survival among men with de novo metastatic prostate cancer treated with abiraterone acetate or docetaxel and compared these outcomes to those seen in clinical...
Daniel Geynisman, MD, discusses...
03/18/2021
Journal of Clinical Pathways
Conference Coverage
02/03/2021
Journal of Clinical Pathways
High Costs of Pancreatic Enzyme Replacement Therapy Barrier to Medicare Beneficiary Drug Access
Videos
01/20/2021
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses results from a study assessing out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
Arjun Gupta, MD, discusses...
01/20/2021
Journal of Clinical Pathways
Conference Coverage
01/16/2021
Journal of Clinical Pathways
Conference Coverage
01/15/2021
Journal of Clinical Pathways
Real-World Treatment Patterns, FLT3 Testing, and Outcomes in AML
Videos
01/14/2021
Amer Zeidan, MBBS, MHS, discusses results from a retrospective study examining FLT3 testing trends, treatment patterns, and overall survival in relapsed/refractory AML.
Amer Zeidan, MBBS, MHS, discusses results from a retrospective study examining FLT3 testing trends, treatment patterns, and overall survival in relapsed/refractory AML.
Amer Zeidan, MBBS, MHS,...
01/14/2021
Journal of Clinical Pathways